Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CRDO vs GSK✓SelectedUSD · GSKCRDO vs GSK performance historyLatest closeAs of-15.20%11/20
Stock and ETF performance explorer

CRDO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+449.0%
GSK return
+53.4%
Excess return
+395.6%
Maximum drawdown
-67.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-15.2%-0.1%-15.1%-15.2%
7D-24.1%-5.3%-18.7%-25.3%
30D-45.2%-3.7%-41.6%-45.6%
3M-56.8%-7.3%-49.6%-57.3%
6M-45.4%-4.2%-41.2%-45.4%
YTD-30.6%+0.9%-31.5%-29.7%
1Y-25.9%+7.3%-33.2%-24.4%
3Y+449.0%+52.7%+396.2%+503.8%
All+449.0%+53.4%+395.6%+503.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling